Skip to main content
Top
Published in: Supportive Care in Cancer 11/2009

Open Access 01-11-2009 | Original Article

Changes in symptom clusters in patients undergoing radiation therapy

Authors: Esther Kim, Thierry Jahan, Bradley E. Aouizerat, Marylin J. Dodd, Bruce A. Cooper, Steven M. Paul, Claudia West, Kathryn Lee, Patrick S. Swift, William Wara, Christine Miaskowski

Published in: Supportive Care in Cancer | Issue 11/2009

Login to get access

Abstract

Goals of work

The goals of the study were to determine the occurrence rates for and the severity of symptoms at the middle, end, and 1 month after the completion of radiation therapy (RT), to determine the number and types of symptom clusters at these three time points, and to evaluate for changes over time in these symptom clusters.

Materials and methods

Symptom occurrence and severity were evaluated using the Memorial Symptom Assessment Scale (MSAS) in a sample of patients (n = 160) who underwent RT for breast or prostate cancer. At each time point, an exploratory factor analysis was done to determine the number of symptom clusters (i.e., symptom factors) based on the MSAS symptom severity ratings.

Main results

The majority of the patients were male and married with a mean age of 61.1 years. The five symptoms with the highest occurrence rates across all three time points were lack of energy, pain, difficulty sleeping, feeling drowsy, and sweats. Although the number of symptoms and the specific symptoms within each symptom cluster were not identical across the three time points, three relatively similar symptom clusters (i.e., “mood-cognitive” symptom cluster, “sickness-behavior” symptom cluster, “treatment-related”, or “pain” symptom cluster) were identified in this sample. The internal consistency coefficients for the mood-cognitive symptom cluster and sickness-behavior symptom cluster were adequate at ≥0.68.

Conclusions

Three relatively stable symptom clusters were found across RT. The majority of the symptom cluster severity scores were significantly higher in patients with breast cancer compared to patients with prostate cancer.
Literature
4.
go back to reference Brown TA (2006) Confirmatory factor analysis for applied research. Guilford, New York Brown TA (2006) Confirmatory factor analysis for applied research. Guilford, New York
10.
go back to reference Gleason JF Jr, Case D, Rapp SR, Ip E, Naughton M, Butler JM Jr, McMullen K, Stieber V, Saconn P, Shaw EG (2007) Symptom clusters in patients with newly-diagnosed brain tumors. J Support Oncol 5(427–433):436 Gleason JF Jr, Case D, Rapp SR, Ip E, Naughton M, Butler JM Jr, McMullen K, Stieber V, Saconn P, Shaw EG (2007) Symptom clusters in patients with newly-diagnosed brain tumors. J Support Oncol 5(427–433):436
12.
go back to reference Hadi S, Zhang L, Hird A, de Sa E, Chow E (2008) Validation of symptom clusters in patients with metastatic bone pain. Curr Oncol 15:211–218PubMed Hadi S, Zhang L, Hird A, de Sa E, Chow E (2008) Validation of symptom clusters in patients with metastatic bone pain. Curr Oncol 15:211–218PubMed
17.
go back to reference Muthen BO, Kaplan D (1985) A comparison of some methodologies for the factor analysis of non-normal Likert variables. Br J Math Stat Psychol 38:171–189 Muthen BO, Kaplan D (1985) A comparison of some methodologies for the factor analysis of non-normal Likert variables. Br J Math Stat Psychol 38:171–189
18.
go back to reference Muthen LK, Muthen BO (1998–2008) Mplus User's Guide (5th ed.). Muthen & Muthen, Los Angeles Muthen LK, Muthen BO (1998–2008) Mplus User's Guide (5th ed.). Muthen & Muthen, Los Angeles
19.
go back to reference Muthen LK, Muthen BO (2008) Mplus (Version 5.1). Muthen & Muthen, Los Angles Muthen LK, Muthen BO (2008) Mplus (Version 5.1). Muthen & Muthen, Los Angles
20.
go back to reference Pett MA, Lackey NR, Sullivan JJ (2003) Making sense of factor analysis: the use of factor analyis for instrument development in health care research. Sage, Thousand Oaks, CA Pett MA, Lackey NR, Sullivan JJ (2003) Making sense of factor analysis: the use of factor analyis for instrument development in health care research. Sage, Thousand Oaks, CA
21.
go back to reference Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L et al (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A:1326–1336. doi:10.1016/0959-8049(94) 90182-1 CrossRefPubMed Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L et al (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A:1326–1336. doi:10.​1016/​0959-8049(94) 90182-1 CrossRefPubMed
22.
go back to reference Raykov T, Marcoulides GA (2006) A first course in structural equation modeling. Lawrence Erlbaum, Mahwah Raykov T, Marcoulides GA (2006) A first course in structural equation modeling. Lawrence Erlbaum, Mahwah
24.
go back to reference Wang XS, Fairclough DL, Liao Z, Komaki R, Chang JY, Mobley GM, Cleeland CS (2006) Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol 24:4485–4491. doi:10.1200/JCO.2006.07.1126 CrossRefPubMed Wang XS, Fairclough DL, Liao Z, Komaki R, Chang JY, Mobley GM, Cleeland CS (2006) Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol 24:4485–4491. doi:10.​1200/​JCO.​2006.​07.​1126 CrossRefPubMed
Metadata
Title
Changes in symptom clusters in patients undergoing radiation therapy
Authors
Esther Kim
Thierry Jahan
Bradley E. Aouizerat
Marylin J. Dodd
Bruce A. Cooper
Steven M. Paul
Claudia West
Kathryn Lee
Patrick S. Swift
William Wara
Christine Miaskowski
Publication date
01-11-2009
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 11/2009
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-009-0595-5

Other articles of this Issue 11/2009

Supportive Care in Cancer 11/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine